← Evidence map

ReviewDrugs2020

Inebilizumab: First Approval.

James E FramptonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

69 papers cite itlatest 60 shown

2020
…
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32729016